BR112012017683A2 - Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel - Google Patents

Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel

Info

Publication number
BR112012017683A2
BR112012017683A2 BRBR112012017683-8A BR112012017683A BR112012017683A2 BR 112012017683 A2 BR112012017683 A2 BR 112012017683A2 BR 112012017683 A BR112012017683 A BR 112012017683A BR 112012017683 A2 BR112012017683 A2 BR 112012017683A2
Authority
BR
Brazil
Prior art keywords
nutritional emulsions
soluble protein
protein
calcium
hmb
Prior art date
Application number
BRBR112012017683-8A
Other languages
English (en)
Inventor
Paul W Johns
Ann Kensler
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43904593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012017683(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR112012017683A2 publication Critical patent/BR112012017683A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86—Addition of bitterness inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Emulsões nutritivas compreendnedo hmb de cálcio e proteína solúvel. São divulgadas emulsões nutritivas compreendendo gordura, carboidrato, proteína e hmb de cálcio em que a proteína solúvel compreende de aproximadamente 50% a 100% em peso da proteína total. Também são divulgadas emulsões nutritivas compreendendo gordura, carboidrato, proteína e hmb de cálcio em que a proteína solúvel comrpeende de aproximadamente 50% a 100% em peso da proteína e a emulsão tem uma razão em peso da proteína solúvel para o hmb de cálcio de aproximadamente 5:1 à aproximadamente 12:1. As emulsões nutritivas são surpreendentemente estáveis e geram um mínimo ou nenhum sabor amargo ou gosto posterior com o passar do tempo.
BRBR112012017683-8A 2010-01-29 2011-01-28 Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel BR112012017683A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29956710P 2010-01-29 2010-01-29
PCT/US2011/022928 WO2011094544A1 (en) 2010-01-29 2011-01-28 Nutritional emulsions comprising calcium hmb and soluble protein

Publications (1)

Publication Number Publication Date
BR112012017683A2 true BR112012017683A2 (pt) 2015-09-01

Family

ID=43904593

Family Applications (1)

Application Number Title Priority Date Filing Date
BRBR112012017683-8A BR112012017683A2 (pt) 2010-01-29 2011-01-28 Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel

Country Status (18)

Country Link
US (1) US20110256297A1 (pt)
EP (2) EP2792251B2 (pt)
JP (2) JP5734314B2 (pt)
CN (2) CN104643067B (pt)
AU (1) AU2011210764A1 (pt)
BR (1) BR112012017683A2 (pt)
CA (1) CA2785522C (pt)
CO (1) CO6561822A2 (pt)
EC (1) ECSP12012045A (pt)
ES (2) ES2485312T3 (pt)
HK (2) HK1165228A1 (pt)
IL (1) IL220587A0 (pt)
MX (2) MX2012008786A (pt)
PE (1) PE20121726A1 (pt)
RU (1) RU2012125877A (pt)
SG (1) SG182809A1 (pt)
TW (1) TWI519242B (pt)
WO (1) WO2011094544A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102711524B (zh) 2010-01-29 2014-09-10 雅培制药有限公司 包含hmb钙的营养乳剂
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
CA2785523A1 (en) 2010-01-29 2011-08-04 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
CA2799432C (en) * 2010-05-17 2015-11-17 Abbott Laboratories Method of making nutritional emulsions containing encapsulated oils
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
JP6420156B2 (ja) * 2012-03-09 2018-11-07 フォンテラ コ−オペレイティブ グループ リミティド カゼイン組成物の使用
US20150119339A1 (en) * 2012-06-11 2015-04-30 Abbott Laboratories Use of hmb to improve health outcomes for hospitalized patients
WO2014047497A1 (en) * 2012-09-21 2014-03-27 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
WO2014078509A1 (en) * 2012-11-14 2014-05-22 Abbott Laboratories Stabilized liquid nutritionals including insoluble calcium salts
US20160029683A1 (en) * 2013-03-15 2016-02-04 Abbott Laboratories Low calorie infant formula containing beta-hydroxy-beta-methylbutyric acid
EP2986163B1 (en) * 2013-03-15 2017-04-19 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein
WO2014152616A1 (en) * 2013-03-15 2014-09-25 Abbott Laboratories Low calorie infant formula containing
JP6437272B2 (ja) * 2014-10-29 2018-12-12 ライオン株式会社 組成物
US10758504B2 (en) * 2015-09-16 2020-09-01 Metabolic Technologies, Inc. Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
CN106387586A (zh) * 2016-08-31 2017-02-15 宣城柏维力生物工程有限公司 乳清蛋白β羟基‑甲基丁酸钙运动饮料及其生产工艺
JP7083254B2 (ja) * 2018-02-07 2022-06-10 テーブルマーク株式会社 β－ヒドロキシ－β－メチル酪酸カルシウム塩（ＨＭＢＣａ）の苦味が低減された飲食品組成物
WO2019229215A2 (de) * 2018-05-30 2019-12-05 DÖHLER GmbH Hochdruckverfahren, insbesondere zur haltbarmachung von lebensmitteln, pharmazeutika und kosmetika, sowie hochdruckvorrichtung
CN109329949A (zh) * 2018-12-07 2019-02-15 广东君悦营养医学有限公司 包含hmb钙和乳清蛋白的全营养混悬液及制备方法
CN109393493A (zh) * 2018-12-17 2019-03-01 广东君悦营养医学有限公司 一种含hmb钙的预消化型全营养液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028440A (en) * 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US5726146A (en) * 1994-12-06 1998-03-10 Natural Supplement Association, Incorporated Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
DE29707308U1 (de) * 1997-04-23 1997-06-26 Kunz Armin Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus
CZ20021346A3 (cs) * 1999-10-18 2003-06-18 Muscletech Research And Development Inc. Potravinový doplněk pro růst svalové hmoty a síly
US6521591B1 (en) * 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US8067052B2 (en) * 2005-02-25 2011-11-29 Siddharth Shastri Nutritional composition and a container for the convenient transport and storage of the nutritional composition
RU2469719C2 (ru) * 2005-12-19 2012-12-20 Абботт Лаборэтриз СПОСОБ ЛЕЧЕНИЯ АЛЛЕРГИИ, СПОСОБ ЛЕЧЕНИЯ АСТМЫ, СПОСОБ СНИЖЕНИЯ РИСКА РАЗВИТИЯ ИНФЕКЦИИ И СПОСОБ ЛЕЧЕНИЯ СОСТОЯНИЯ, ХАРАКТЕРИЗУЮЩЕГОСЯ ДИСБАЛАНСОМ СОДЕРЖАНИЯ ЦИТОКИНОВ ТИПОВ 1 И 2, ПОСРЕДСТВОМ β-ГИДРОКСИ-β-МЕТИЛБУТИРАТА
CN101569412B (zh) * 2009-06-01 2012-12-05 北京康比特体育科技股份有限公司 一种运动营养补剂及其应用
PL217815B1 (pl) * 2009-12-14 2014-08-29 Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością Napój izotoniczny z chelatami

Also Published As

Publication number Publication date
JP2015163074A (ja) 2015-09-10
HK1202231A1 (zh) 2015-09-25
CA2785522C (en) 2015-09-29
CO6561822A2 (es) 2012-11-15
AU2011210764A1 (en) 2012-07-05
JP6033911B2 (ja) 2016-11-30
ES2583839T3 (es) 2016-09-22
ES2583839T5 (es) 2022-11-15
EP2442675B1 (en) 2014-05-21
MX2012008786A (es) 2012-08-17
JP2013517804A (ja) 2013-05-20
CN104643067B (zh) 2018-02-06
CN102711525B (zh) 2015-03-11
EP2442675A1 (en) 2012-04-25
MX340405B (es) 2016-07-07
TWI519242B (zh) 2016-02-01
JP5734314B2 (ja) 2015-06-17
HK1165228A1 (en) 2012-10-05
CN104643067A (zh) 2015-05-27
TW201200033A (en) 2012-01-01
ES2485312T3 (es) 2014-08-13
EP2792251B1 (en) 2016-07-13
PE20121726A1 (es) 2013-01-16
EP2792251B2 (en) 2022-08-31
ECSP12012045A (es) 2012-08-31
EP2792251A1 (en) 2014-10-22
WO2011094544A1 (en) 2011-08-04
CA2785522A1 (en) 2011-08-04
IL220587A0 (en) 2012-08-30
SG182809A1 (en) 2012-09-27
RU2012125877A (ru) 2014-03-10
CN102711525A (zh) 2012-10-03
US20110256297A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
BR112012017683A2 (pt) Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel
BR112012017690A2 (pt) Emulsões nutricionais compreendendo hmb de cálcio
BR112021024686A2 (pt) Produto de bolsa de nicotina
CY1123580T1 (el) Συντετμημενες πρωτεϊνες συγχωνευσης actriib-fc
BR112012031183A2 (pt) líquidos nutricionais substancialmente claros compreendendo proteína de cálcio hmb e solúvel
CY1118691T1 (el) Συνθεσεις και μεθοδοι χρησης για αντισωματα κατα σκληροστινης
MA35458B1 (fr) Variants du facteur de croissance des fibroblastes 21
BR112017013661A8 (pt) Conjugado derivado de antraciclina (pnu), conjugado de fármaco-proteína de ligação (bpdc), método para a produção de um conjugado de fármaco-proteína de ligação (bpdc), uso de um conjugado de proteína de ligação-fármaco (bpdc) e composição farmacêutica
BR112012009487A2 (pt) formulações de espessante estáveis
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
BR112012028291A2 (pt) composições farmacêuticas e métodos para sua produção
CL2007002084A1 (es) Ingrediente lacteo enriquecido en fosfolipidos y esfingolipidos, en que el porcentaje de fosfolipidos es mayor a 36% con respeto al peso de la materia seca del ingrediente; procedimiento de obtencion; composicion alimentaria o aditivo que lo contiene; composicion farmaceutica o cosmetica; y su uso.
MX2018003569A (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
BR112014009376A2 (pt) composições
CO6231001A2 (es) Estabilizacion de vitamina b12
BR112018070060A2 (pt) composições para tratamento bucal com uma exibição de sabor eficiente
DE602006006046D1 (de) Verwendung nativer peptide und deren optimierter derivate zur impfung
CO6400235A2 (es) Tensiactivos reconstituidos que tienen propiedades mejoradas
CY1124010T1 (el) Μια φαρμακευτικη συνθεση για την παρεμποδιση της διατροφικης παχυσαρκιας
BR112013016590A2 (pt) uso de estabilizantes de glutamina
CY1115955T1 (el) Ενα στερεο φαρμακευτικο σκευασμα
CY1115734T1 (el) Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη
MX2011008261A (es) FORMULACIONES FARMACEUTICAS DE PEPTIDOS INHIBIDORES DE TGF-ß1.
BR0315941A (pt) Emulsão do tipo água-em-óleo-em-água, composição alimentìcia e método para a produção de uma emulsão

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 27/00 (2016.01), A23L 33/10 (2016.01), A23L 3

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]